Awards and Rankings May 31, 2017

Nine Goodwin Clients Recognized at The 2017 NEVY Awards

Goodwin congratulates our Technology and Life Sciences clients who were honored at the recent New England Venture Capital Association’s awards (the NEVYs). We are privileged to partner with such a talented and innovative group of companies.

Recognized in the Technology Category:

  • Turbonomic was named the Next Pillar Tech Company. Launched in 2010, Turbonomic is one of the fastest growing technology companies in the virtualization and cloud space.
  • Highland Capital Partners was named the Fund of the Year. Highland Capital Partners is a venture capital firm that has raised over $3 billion in committed capital and invested in more than 225 companies.
  • General Catalyst’s Senior associate Juan Luis Leung-Li was named the Rising Star VC. General Catalyst is a venture capital firm focused on early stage and growth investments. Juan Luis Leung-Li focuses on early stage investments for entrepreneurs in the Boston area.

Recognized in the Healthcare & Life Sciences Category:

  • Magenta Therapeutics was named the Hottest Early Stage Startup - Therapeutics.  The company is focused on revolutionizing hematopoietic stem cell transplant for patients with immune and blood-based diseases.
  • Jounce Therapeutics was recognized with the Deal of the Year award for its strategic collaboration with Celgene Corporation to develop the next-generation of immuno-oncology therapies for patients with cancer.
  • Atlas Venture’s Principal Michael Gladstone was named the Rising Star VC. Atlas Venture is an early-stage venture capital firm that invests in life sciences startup companies across the U.S. Michael Gladstone focuses on new platform company creation and operations. He was a member of the founding teams of several Atlas Venture-originated companies, including Padlock Therapeutics Surface Oncology, and IFM Therapeutics.
  • Nimbus Apollo was recognized with the Exit of the Year award. Gilead Sciences acquired Nimbus Apollo, Inc., a wholly-owned subsidiary of Nimbus Therapeutics, a biotechnology company focused on harnessing the power of computational chemistry to design breakthrough drugs for serious, underserved human diseases. 
  • Rest Devices was named the Digital Health Company of the Year. Rest Devices leads the market in connected devices for the nursery. Its first product, Mimo, is the first in-market smart wearable baby monitor, pushing data on respiration, body position, skin temperature, audio, and activity level real-time to a parent’s smartphone.
  • Third Rock Ventures was named the Fund of the Year. Third Rock Ventures is venture capital firm that invests in biotechnology startups.

The NEVYs are Boston’s premier celebration of the venture ecosystem, uniting the tech and life science communities. To learn more about the 2017 awards, please click here.